Abstract
Abstract
Sarcomatoid carcinoma is a rare malignancy with strong invasion and high malignancy, and it contains epithelial cells and sarcoma or sarcoma-like components. Here we reported one case of pulmonary sarcomatoid carcinoma in a 55-year-old COPD male who presented with wet coughing and hemoptysis, chest CT showed a mass in the left lung. According to tracheoscopy, the patient was initially diagnosed as Aspergillus, but was eventually corrected by histology and Immunohistochemistry of lung puncture specimens. In this study, we describe the diagnostic procedure, as well as chemotherapy and targeted therapy response in this pulmonary sarcomatoid carcinoma patient with EGFR mutation, and review relevant literature.
Publisher
Research Square Platform LLC
Reference20 articles.
1. Mlika M, Anjum F, El Mezni F. Pleuropulmonary Blastoma. StatPearls. edn. Treasure Island (FL); 2022.
2. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification;Sauter JL;J Thorac Oncol,2022
3. Molecular Characterization and Antifungal Susceptibility of Aspergillus spp. among Patients with Underlying Lung Diseases;Moglad E;Trop Med Infect Dis,2022
4. Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients;Maneenil K;Clin Lung Cancer,2018
5. Lung neuroendocrine neoplasms: recent progress and persistent challenges;Rekhtman N;Mod Pathol,2022